These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31181164)

  • 1. Analysis of an Integrated Human Multiorgan Microphysiological System for Combined Tolcapone Metabolism and Brain Metabolomics.
    Wang X; Cirit M; Wishnok JS; Griffith LG; Tannenbaum SR
    Anal Chem; 2019 Jul; 91(13):8667-8675. PubMed ID: 31181164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of metabolite profiles of the catechol-O-methyl transferase inhibitor tolcapone in rat urine using LC/MS-based metabonomics analysis.
    Sun J; Von Tungeln LS; Hines W; Beger RD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2557-65. PubMed ID: 19615953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing quasi-steady state operations of microphysiological systems (MPS) using tissue-specific metabolic dependencies.
    Maass C; Dallas M; LaBarge ME; Shockley M; Valdez J; Geishecker E; Stokes CL; Griffith LG; Cirit M
    Sci Rep; 2018 May; 8(1):8015. PubMed ID: 29789564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and elimination of the catechol-o-methyltransferase inhibitor tolcapone in the horse.
    Stanley S; Van den Berg K; Foo HC; Deng D
    Drug Test Anal; 2019 Apr; 11(4):578-585. PubMed ID: 30367738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro metabolism of tolcapone to reactive intermediates: relevance to tolcapone liver toxicity.
    Smith KS; Smith PL; Heady TN; Trugman JM; Harman WD; Macdonald TL
    Chem Res Toxicol; 2003 Feb; 16(2):123-8. PubMed ID: 12588182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of key metabolites during cisplatin-induced acute kidney injury using an HPLC-TOF/MS-based non-targeted urine and kidney metabolomics approach in rats.
    Qu X; Gao H; Sun J; Tao L; Zhang Y; Zhai J; Song Y; Hu T; Li Z
    Toxicology; 2020 Feb; 431():152366. PubMed ID: 31926187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ingenuity pathways analysis of urine metabolomics phenotypes toxicity of Chuanwu in Wistar rats by UPLC-Q-TOF-HDMS coupled with pattern recognition methods.
    Dong H; Zhang A; Sun H; Wang H; Lu X; Wang M; Ni B; Wang X
    Mol Biosyst; 2012 Apr; 8(4):1206-21. PubMed ID: 22282765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel with Exposome Markers in Crohn's Disease.
    Lai Y; Xue J; Liu CW; Gao B; Chi L; Tu P; Lu K; Ru H
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30691236
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism and excretion of tolcapone, a novel inhibitor of catechol-O-methyltransferase.
    Jorga K; Fotteler B; Heizmann P; Gasser R
    Br J Clin Pharmacol; 1999 Oct; 48(4):513-20. PubMed ID: 10583021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary metabolic phenotyping of mucopolysaccharidosis type I combining untargeted and targeted strategies with data modeling.
    Tebani A; Schmitz-Afonso I; Abily-Donval L; Héron B; Piraud M; Ausseil J; Brassier A; De Lonlay P; Zerimech F; Vaz FM; Gonzalez BJ; Marret S; Afonso C; Bekri S
    Clin Chim Acta; 2017 Dec; 475():7-14. PubMed ID: 28982054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Profiling of Fecal Metabolome of Mice by Integrated Chemical Isotope Labeling-Mass Spectrometry Analysis.
    Yuan BF; Zhu QF; Guo N; Zheng SJ; Wang YL; Wang J; Xu J; Liu SJ; He K; Hu T; Zheng YW; Xu FQ; Feng YQ
    Anal Chem; 2018 Mar; 90(5):3512-3520. PubMed ID: 29406693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics.
    Kumar BS; Chung BC; Kwon OS; Jung BH
    J Appl Toxicol; 2012 Jul; 32(7):505-20. PubMed ID: 22131085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of chemical isotope labeling LC-MS for tissue metabolomics and its application for brain and liver metabolome profiling in Alzheimer's disease mouse model.
    Wang X; Han W; Yang J; Westaway D; Li L
    Anal Chim Acta; 2019 Mar; 1050():95-104. PubMed ID: 30661596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature.
    Sarode GV; Kim K; Kieffer DA; Shibata NM; Litwin T; Czlonkowska A; Medici V
    Metabolomics; 2019 Mar; 15(3):43. PubMed ID: 30868361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The liver toxicity biomarker study phase I: markers for the effects of tolcapone or entacapone.
    McBurney RN; Hines WM; VonTungeln LS; Schnackenberg LK; Beger RD; Moland CL; Han T; Fuscoe JC; Chang CW; Chen JJ; Su Z; Fan XH; Tong W; Booth SA; Balasubramanian R; Courchesne PL; Campbell JM; Graber A; Guo Y; Juhasz P; Li TY; Lynch MD; Morel NM; Plasterer TN; Takach EJ; Zeng C; Beland FA
    Toxicol Pathol; 2012 Aug; 40(6):951-64. PubMed ID: 22573522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of pancreas-muscle-liver microphysiological system (MPS) for reproducing glucose metabolism.
    Lee DW; Lee SH; Choi N; Sung JH
    Biotechnol Bioeng; 2019 Dec; 116(12):3433-3445. PubMed ID: 31429925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Untargeted metabolomics.
    Vinayavekhin N; Saghatelian A
    Curr Protoc Mol Biol; 2010 Apr; Chapter 30():Unit 30.1.1-24. PubMed ID: 20373502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Drug-Induced Toxicity Biomarkers in the Brain Microphysiological System (MPS) Using Targeted and Untargeted Molecular Profiling.
    Mina SG; Alaybeyoglu B; Murphy WL; Thomson JA; Stokes CL; Cirit M
    Front Big Data; 2019; 2():23. PubMed ID: 33693346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients.
    Coene KLM; Kluijtmans LAJ; van der Heeft E; Engelke UFH; de Boer S; Hoegen B; Kwast HJT; van de Vorst M; Huigen MCDG; Keularts IMLW; Schreuder MF; van Karnebeek CDM; Wortmann SB; de Vries MC; Janssen MCH; Gilissen C; Engel J; Wevers RA
    J Inherit Metab Dis; 2018 May; 41(3):337-353. PubMed ID: 29453510
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.